Verrica Pharmaceuticals Inc (VRCA)
0.9945
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
1.00
+0.01
(+0.55%)
After-Hours: 20:00
Verrica Pharmaceuticals Cash from Financing (Quarterly): -0.397M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.397M |
| June 30, 2024 | -0.64M |
| March 31, 2024 | -0.661M |
| December 31, 2023 | -0.027M |
| September 30, 2023 | 44.04M |
| June 30, 2023 | -0.084M |
| March 31, 2023 | 30.28M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -16.85M |
| June 30, 2022 | -0.001M |
| March 31, 2022 | -0.018M |
| December 31, 2021 | -0.003M |
| September 30, 2021 | 0.043M |
| June 30, 2021 | 0.241M |
| March 31, 2021 | 33.36M |
| December 31, 2020 | 0.445M |
| Date | Value |
|---|---|
| September 30, 2020 | 0.00 |
| June 30, 2020 | -0.09M |
| March 31, 2020 | 34.88M |
| December 31, 2019 | 0.204M |
| September 30, 2019 | 0.004M |
| June 30, 2019 | 0.212M |
| March 31, 2019 | 0.003M |
| December 31, 2018 | 0.009M |
| September 30, 2018 | -1.064M |
| June 30, 2018 | 79.44M |
| March 31, 2018 | 20.99M |
| December 31, 2017 | 10.11M |
| September 30, 2017 | 0.965M |
| June 30, 2017 | 1.158M |
| March 31, 2017 | 0.482M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-16.85M
Minimum
Sep 2022
44.04M
Maximum
Sep 2023
6.236M
Average
-0.0005M
Median
Cash from Financing (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | -499.12M |
| Elite Pharmaceuticals Inc | -0.3207M |
| Eagle Pharmaceuticals Inc | -6.411M |
| TELA Bio Inc | 0.098M |
| Terns Pharmaceuticals Inc | 163.29M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.558M |
| Cash from Investing (Quarterly) | -0.016M |
| Free Cash Flow | -59.62M |
| Free Cash Flow Per Share (Quarterly) | -0.1832 |
| Free Cash Flow to Equity (Quarterly) | -9.128M |
| Free Cash Flow Yield | -128.9% |